# Cytokine-induced Memory-like NK Cells in Relapsed/Refractory AML and MDS

> **NCT04893915** · PHASE2 · WITHDRAWN · sponsor: **Washington University School of Medicine**

## Conditions studied

- Relapsed Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- Myelodysplastic Syndromes

## Interventions

- **BIOLOGICAL:** Cytokine-induced memory-like NK cells
- **DRUG:** Fludarabine
- **DRUG:** Cyclophosphamide
- **PROCEDURE:** Donor Leukapheresis
- **DRUG:** Interleukin-2

## Key facts

- **NCT ID:** NCT04893915
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-06-30
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No funding support
- **Last updated:** 2022-03-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04893915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04893915, "Cytokine-induced Memory-like NK Cells in Relapsed/Refractory AML and MDS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04893915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*